{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:03:49Z","timestamp":1740107029500,"version":"3.37.3"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T00:00:00Z","timestamp":1692835200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100013327","name":"H. Lundbeck A\/S","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013327","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Connecticut Research Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1007\/s00213-023-06439-y","type":"journal-article","created":{"date-parts":[[2023,8,24]],"date-time":"2023-08-24T10:02:13Z","timestamp":1692871333000},"page":"2173-2185","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effort-related effects of chronic administration of the DA D2 receptor antagonist haloperidol via subcutaneous programmable minipumps: Reversal by co-administration of the adenosine A2A antagonist istradefylline"],"prefix":"10.1007","volume":"240","author":[{"given":"Renee A.","family":"Rotolo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alev","family":"Ecevitoglu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rose E.","family":"Presby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna","family":"Lindgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cedric","family":"Mombereau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrene","family":"Nicholas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alana","family":"Moore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gayle A.","family":"Edelstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Merce","family":"Correa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John D.","family":"Salamone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,24]]},"reference":[{"issue":"1","key":"6439_CR1","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.vascn.2008.09.002","volume":"59","author":"C Abe","year":"2009","unstructured":"Abe C, Tashiro T, Tanaka K, Ogihara R, Morita H (2009) A novel type of implantable and programmable infusion pump for small laboratory animals. J Pharmacol Toxicol Methods 59(1):7\u201312. https:\/\/doi.org\/10.1016\/j.vascn.2008.09.002","journal-title":"J Pharmacol Toxicol Methods"},{"key":"6439_CR2","doi-asserted-by":"publisher","first-page":"24","DOI":"10.4236\/apd.2016.52004","volume":"5","author":"K Abe","year":"2016","unstructured":"Abe K, Fujita M, Yoshikawa H (2016) Effectiveness of Istradefylline for Fatigue and Quality of Life in Parkinson\u2019s Disease Patients\u2019 and of Their Caregivers\u2019. Adv Parkinson\u2019s Dis 5:24\u201328","journal-title":"Adv Parkinson\u2019s Dis"},{"issue":"2","key":"6439_CR3","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/s0306-4522(99)00004-4","volume":"92","author":"JE Aberman","year":"1999","unstructured":"Aberman JE, Salamone JD (1999) Nucleus accumbens dopamine depletions make rats more sensitive to high ratio requirements but do not impair primary food reinforcement. Neuroscience 92(2):545\u2013552. https:\/\/doi.org\/10.1016\/s0306-4522(99)00004-4","journal-title":"Neuroscience"},{"issue":"3","key":"6439_CR4","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1176\/appi.ajp.163.3.488","volume":"163","author":"JF Artaloytia","year":"2006","unstructured":"Artaloytia JF, Arango C, Lahti A et al (2006) Negative signs and symptoms secondary to antipsychotics: a double-blind, randomized trial of a single dose of placebo, haloperidol, and risperidone in healthy volunteers. Am J Psychiatry 163(3):488\u2013493. https:\/\/doi.org\/10.1176\/appi.ajp.163.3.488","journal-title":"Am J Psychiatry"},{"issue":"2","key":"6439_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1037\/bne0000361","volume":"134","author":"MR Bailey","year":"2020","unstructured":"Bailey MR, Chun E, Schipani E, Balsam PD, Simpson EH (2020) Dissociating the effects of dopamine D2 receptors on effort-based versus value-based decision making using a novel behavioral approach. Behav Neurosci 134(2):101\u2013118. https:\/\/doi.org\/10.1037\/bne0000361","journal-title":"Behav Neurosci"},{"issue":"4","key":"6439_CR6","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1093\/schbul\/sbx063","volume":"43","author":"DM Barch","year":"2017","unstructured":"Barch DM, Gold JM, Kring AM (2017) Paradigms for assessing hedonic processing and motivation in humans: relevance to understanding negative symptoms in psychopathology. Schizophr Bull 43(4):701\u2013705","journal-title":"Schizophr Bull"},{"issue":"5","key":"6439_CR7","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.euroneuro.2013.10.001","volume":"24","author":"SA Barnes","year":"2014","unstructured":"Barnes SA, Der-Avakian A, Markou A (2014) Anhedonia, avolition, and anticipatory deficits: assessments in animals with relevance to the negative symptoms of schizophrenia. Eur Neuropsychopharmacol 24(5):744\u2013758. https:\/\/doi.org\/10.1016\/j.euroneuro.2013.10.001","journal-title":"Eur Neuropsychopharmacol"},{"issue":"1","key":"6439_CR8","first-page":"18","volume":"30","author":"I Bitter","year":"2015","unstructured":"Bitter I, Feh\u00e9r L, T\u00e9nyi T, Czobor P (2015) Treatment adherence and insight in schizophrenia. Psychiatr Hung 30(1):18\u201326","journal-title":"Psychiatr Hung"},{"issue":"5","key":"6439_CR9","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1177\/2045125314540297","volume":"4","author":"S Brissos","year":"2014","unstructured":"Brissos S, Veguilla MR, Taylor D, Balanz\u00e1-Martinez V (2014) The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal. Ther Adv Psychopharmacol 4(5):198\u2013219. https:\/\/doi.org\/10.1177\/2045125314540297","journal-title":"Ther Adv Psychopharmacol"},{"key":"6439_CR10","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0165-0327(99)00068-3","volume":"57","author":"MP Caligiuri","year":"2000","unstructured":"Caligiuri MP, Ellwanger J (2000) Motor and cognitive aspects of motor retardation in depression. J Affect Disord 57:83\u201393","journal-title":"J Affect Disord"},{"key":"6439_CR11","doi-asserted-by":"publisher","first-page":"940672","DOI":"10.3389\/fnbeh.2022.940672","volume":"16","author":"T Canonica","year":"2022","unstructured":"Canonica T, Zalachoras I (2022) Motivational disturbances in rodent models of neuropsychiatric disorders. Front Behav Neurosci 16:940672. https:\/\/doi.org\/10.3389\/fnbeh.2022.940672","journal-title":"Front Behav Neurosci"},{"issue":"1","key":"6439_CR12","first-page":"25","volume":"3","author":"G Chouinard","year":"1993","unstructured":"Chouinard G, Jones B, Remington G et al (1993) A Canadian multicenter placebo-controlled study of fixed doses of risperidone and haloperidol in the treatment of chronic schizophrenic patients [published correction appears in J Clin Psychopharmacol 1993 Apr; 13(2):149]. J Clin Psychopharmacol 3(1):25\u201340","journal-title":"J Clin Psychopharmacol"},{"issue":"1","key":"6439_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/0091-3057(94)90460-x","volume":"49","author":"MS Cousins","year":"1994","unstructured":"Cousins MS, Salamone JD (1994) Nucleus accumbens dopamine depletions in rats affect relative response allocation in a novel cost\/benefit procedure. Pharmacol Biochem Behav 49(1):85\u201391. https:\/\/doi.org\/10.1016\/0091-3057(94)90460-x","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"6439_CR14","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1177\/2167702620901558","volume":"8","author":"AJ Culbreth","year":"2020","unstructured":"Culbreth AJ, Moran EK, Kandala S, Westbrook A, Barch DM (2020) Effort, avolition and motivational experience in schizophrenia: Analysis of behavioral and neuroimaging data with relationships to daily motivational experience. Clin Psychol Sci 8(3):555\u2013568. https:\/\/doi.org\/10.1177\/2167702620901558","journal-title":"Clin Psychol Sci"},{"key":"6439_CR15","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1017\/S1461145704004729","volume":"8","author":"K Demyttenaere","year":"2005","unstructured":"Demyttenaere K, De Fruyt J, Stahl SM (2005) The many faces of fatigue in major depressive disorder. Int J Neuropsychopharmacol 8:93\u2013105. https:\/\/doi.org\/10.1017\/S1461145704004729","journal-title":"Int J Neuropsychopharmacol"},{"issue":"2","key":"6439_CR16","first-page":"7","volume":"14","author":"K Eklund","year":"1991","unstructured":"Eklund K, Forsman A (1991) Minimal effective dose and relapse - double-blind trial: haloperidol decanoate vs. placebo. Clin Neuropharmacol 14(2):7\u201315 (CSzG: Ref 747)","journal-title":"Clin Neuropharmacol"},{"issue":"12","key":"6439_CR17","doi-asserted-by":"publisher","first-page":"2378","DOI":"10.1016\/j.clinthera.2008.12.020","volume":"30","author":"R Emsley","year":"2008","unstructured":"Emsley R, Oosthuizen P, Koen L, Niehaus DJ, Medori R, Rabinowitz J (2008) Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies. Clin Ther 30(12):2378\u20132386. https:\/\/doi.org\/10.1016\/j.clinthera.2008.12.020","journal-title":"Clin Ther"},{"issue":"6","key":"6439_CR18","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1007\/s00213-021-05795-x","volume":"238","author":"EL Errante","year":"2021","unstructured":"Errante EL, Chakkalamuri M, Akinbo OI, Yohn SE, Salamone JD, Matuszewich L (2021) Sex differences in effort-related decision-making: role of dopamine D2 receptor antagonism. Psychopharmacology 238(6):1609\u20131619. https:\/\/doi.org\/10.1007\/s00213-021-05795-x","journal-title":"Psychopharmacology"},{"key":"6439_CR19","doi-asserted-by":"publisher","unstructured":"Essali A, Turkmani K, Aboudamaah S, AbouDamaah A, Diaa Aldeen MR, Marwa ME, AlMounayer N (2019) Haloperidol discontinuation for people with schizophrenia. Cochrane Database Syst Rev 4(4):CD011408. https:\/\/doi.org\/10.1002\/14651858.CD011408.pub2","DOI":"10.1002\/14651858.CD011408.pub2"},{"key":"6439_CR20","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.neuroscience.2009.12.056","volume":"166","author":"AM Farrar","year":"2010","unstructured":"Farrar AM, Segovia KN, Randall PA, Nunes EJ, Collins LE, Stopper CM, Port RG, Hockemeyer J, M\u00fcller CE, Correa M, Salamone JD (2010) Nucleus accumbens and effort-related functions: behavioral and neural markers of the interactions between adenosine A2A and dopamine D2 receptors. Neuroscience 166:1056\u20131067","journal-title":"Neuroscience"},{"key":"6439_CR21","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1002\/da.22199","volume":"31","author":"M Fava","year":"2014","unstructured":"Fava M, Ball S, Nelson JC, Sparks J, Konechnik T, Classi P et al (2014) Clinical relevance of fatigue as a residual symptom in major depressive disorder. Depress Anxiety 31:250\u2013257","journal-title":"Depress Anxiety"},{"issue":"1\u20133","key":"6439_CR22","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.schres.2015.09.012","volume":"169","author":"G Fervaha","year":"2015","unstructured":"Fervaha G, Foussias G, Takeuchi H, Agid O, Remington G (2015) Measuring motivation in people with schizophrenia. Schizophr Res 169(1\u20133):423\u2013426. https:\/\/doi.org\/10.1016\/j.schres.2015.09.012","journal-title":"Schizophr Res"},{"key":"6439_CR23","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/mds.21240","volume":"22","author":"JH Friedman","year":"2007","unstructured":"Friedman JH, Brown RG, Comella C, Garber CE et al (2007) Fatigue in Parkinson\u2019s Disease: A review. Mov Disord 22:297\u2013308","journal-title":"Mov Disord"},{"key":"6439_CR24","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.bbr.2013.09.050","volume":"257","author":"J Gao","year":"2013","unstructured":"Gao J, Li M (2013) Time-dependence of risperidone and asenapine sensitization and associated D2 receptor mechanism. Behav Brain Res 257:286\u2013294. https:\/\/doi.org\/10.1016\/j.bbr.2013.09.050","journal-title":"Behav Brain Res"},{"issue":"2","key":"6439_CR25","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.biopsych.2012.12.022","volume":"74","author":"JM Gold","year":"2013","unstructured":"Gold JM, Strauss GP, Waltz JA, Robinson BM, Brown JK, Frank MJ (2013) Negative symptoms of schizophrenia are associated with abnormal effort-cost computations. Biol Psychiatry 74(2):130\u2013136. https:\/\/doi.org\/10.1016\/j.biopsych.2012.12.022","journal-title":"Biol Psychiatry"},{"issue":"1","key":"6439_CR26","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s40263-015-0308-1","volume":"30","author":"RC Harvey","year":"2016","unstructured":"Harvey RC, James AC, Shields GE (2016) A Systematic Review and Network Meta-Analysis to Assess the Relative Efficacy of Antipsychotics for the Treatment of Positive and Negative Symptoms in Early-Onset Schizophrenia. CNS Drugs 30(1):27\u201339. https:\/\/doi.org\/10.1007\/s40263-015-0308-1","journal-title":"CNS Drugs"},{"key":"6439_CR27","doi-asserted-by":"crossref","unstructured":"Kelley ME, van Kammen DP, Allen DN (1999) Empirical validation of primary negative symptoms: independence from effects of medication and psychosis. Am J Psychiat 156 (3), 406\u2013411. https:\/\/doi-org.ezproxy.lib.uconn.edu\/10.1176","DOI":"10.1176\/ajp.156.3.406"},{"issue":"5","key":"6439_CR28","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.euroneuro.2013.06.007","volume":"24","author":"AM Kring","year":"2014","unstructured":"Kring AM, Barch DM (2014) The motivation and pleasure dimension of negative symptoms: neural substrates and behavioral outputs. Eur Neuropsychopharmacol 24(5):725\u2013736. https:\/\/doi.org\/10.1016\/j.euroneuro.2013.06.007","journal-title":"Eur Neuropsychopharmacol"},{"key":"6439_CR29","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/0006-3223(94)00327-Y","volume":"37","author":"M Kurachi","year":"1995","unstructured":"Kurachi M, Shibata R, Murata M, Tanii Y (1995) Parallel development of dopamine metabolism tolerance in the rat prefrontal cortex, caudate-putamen, and amygdala following haloperidol decanoate administration. Biol Psychiat 37:487\u2013490","journal-title":"Biol Psychiat"},{"key":"6439_CR30","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1177\/0269881116654697","volume":"30","author":"M Li","year":"2016","unstructured":"Li M (2016) Antipsychotic-induced sensitization and tolerance: Behavioral characteristics, developmental impacts, and neurobiological mechanisms. J Psychopharmacol 30:749\u2013770. https:\/\/doi.org\/10.1177\/0269881116654697","journal-title":"J Psychopharmacol"},{"issue":"1","key":"6439_CR31","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3758\/s13415-011-0068-4","volume":"12","author":"B Mai","year":"2012","unstructured":"Mai B, Sommer S, Hauber W (2012) Motivational states influence effort-based decision making in rats: the role of dopamine in the nucleus accumbens. Cogn Affect Behav Neurosci 12(1):74\u201384. https:\/\/doi.org\/10.3758\/s13415-011-0068-4","journal-title":"Cogn Affect Behav Neurosci"},{"issue":"6","key":"6439_CR32","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1002\/hup.2350","volume":"28","author":"S Mas","year":"2013","unstructured":"Mas S, Gass\u00f3 P, Fern\u00e1ndez de Bobadilla R, Arnaiz JA, Bernardo M, Lafuente A (2013) Secondary nonmotor negative symptoms in healthy volunteers after single doses of haloperidol and risperidone: a double-blind, crossover, placebo-controlled trial. Hum Psychopharmacol. 28(6):586\u201393. https:\/\/doi.org\/10.1002\/hup.2350","journal-title":"Hum Psychopharmacol."},{"issue":"19","key":"6439_CR33","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.1001\/jama.2014.4310","volume":"311","author":"JP McEvoy","year":"2014","unstructured":"McEvoy JP, Byerly M, Hamer RM et al (2014) Effectiveness of paliperidone palmitate vs haloperidol decanoate for maintenance treatment of schizophrenia: a randomized clinical trial. JAMA 311(19):1978\u20131987. https:\/\/doi.org\/10.1001\/jama.2014.4310","journal-title":"JAMA"},{"key":"6439_CR34","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s00213-008-1441-z","volume":"204","author":"AM Mott","year":"2009","unstructured":"Mott AM, Nunes EJ, Collins LE, Port RG, Sink KS, Hockemeyer J, M\u00fcller CE, Salamone JD (2009) The adenosine A2A MSX-3 reverses the effects of the dopamine antagonist haloperidol on effort-related decision making in a t-maze cost\/benefit procedure. Psychopharmacology 204:103\u2013112","journal-title":"Psychopharmacology"},{"key":"6439_CR35","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jns.2018.11.005","volume":"396","author":"H Nagayama","year":"2019","unstructured":"Nagayama H, Kano O, Murakami H, Ono K, Hamada M, Toda T, Sengoku R, Shimo Y, Hattori N (2019) Effect of istradefylline on mood disorders in Parkinson\u2019s disease. J Neurol Sci 396:78\u201383. https:\/\/doi.org\/10.1016\/j.jns.2018.11.005","journal-title":"J Neurol Sci"},{"key":"6439_CR36","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/B978-0-12-801022-8.00009-X","volume":"119","author":"M Nomoto","year":"2014","unstructured":"Nomoto M, Nagai M, Nishikawa N (2014) Clinical nonmotor aspect of A2A antagonist in PD treatment. Int Rev Neurobiol 119:191\u2013194. https:\/\/doi.org\/10.1016\/B978-0-12-801022-8.00009-X","journal-title":"Int Rev Neurobiol"},{"issue":"1","key":"6439_CR37","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.neuroscience.2010.05.068","volume":"170","author":"EJ Nunes","year":"2010","unstructured":"Nunes EJ, Randall PA, Santerre JL, Given AB, Sager TN, Correa M, Salamone JD (2010) Differential effects of selective adenosine antagonists on the effort-related impairments induced by dopamine D1 and D2 antagonism. Neuroscience 170(1):268\u2013280. https:\/\/doi.org\/10.1016\/j.neuroscience.2010.05.068","journal-title":"Neuroscience"},{"issue":"49","key":"6439_CR38","doi-asserted-by":"publisher","first-page":"19120","DOI":"10.1523\/JNEUROSCI.2730-13.2013","volume":"33","author":"EJ Nunes","year":"2013","unstructured":"Nunes EJ, Randall PA, Hart EE, Freeland C, Yohn SE, Baqi Y, M\u00fcller CE, L\u00f3pez-Cruz L, Correa M, Salamone JD (2013) Effort-related motivational effects of the VMAT-2 inhibitor tetrabenazine: implications for animal models of the motivational symptoms of depression. J Neurosci 33(49):19120\u201319130. https:\/\/doi.org\/10.1523\/JNEUROSCI.2730-13.2013","journal-title":"J Neurosci"},{"issue":"5\u20136","key":"6439_CR39","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1016\/j.neuropharm.2011.12.033","volume":"62","author":"M Pardo","year":"2012","unstructured":"Pardo M, Lopez-Cruz L, Valverde O, Ledent C, Baqi Y, M\u00fcller CE, Salamone JD, Correa M (2012) Adenosine A2A receptor antagonism and genetic deletion attenuate the effects of dopamine D2 antagonism on effort-based decision making in mice. Neuropharmacology 62(5\u20136):2068\u20132077. https:\/\/doi.org\/10.1016\/j.neuropharm.2011.12.033","journal-title":"Neuropharmacology"},{"key":"6439_CR40","doi-asserted-by":"publisher","first-page":"173035","DOI":"10.1016\/j.pbb.2020.173035","volume":"198","author":"M Pardo","year":"2020","unstructured":"Pardo M, Paul NE, Collins-Praino LE, Salamone JD, Correa M (2020) The non-selective adenosine antagonist theophylline reverses the effects of dopamine antagonism on tremor, motor activity and effort-based decision-making. Pharmacol Biochem Behav 198:173035. https:\/\/doi.org\/10.1016\/j.pbb.2020.173035","journal-title":"Pharmacol Biochem Behav"},{"issue":"2","key":"6439_CR41","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1177\/0091217416636601","volume":"51","author":"SV Phan","year":"2016","unstructured":"Phan SV (2016) Medication adherence in patients with schizophrenia. Int J Psychiatry Med 51(2):211\u2013219. https:\/\/doi.org\/10.1177\/0091217416636601","journal-title":"Int J Psychiatry Med"},{"issue":"10","key":"6439_CR42","doi-asserted-by":"publisher","first-page":"e47934","DOI":"10.1371\/journal.pone.0047934","volume":"7","author":"PA Randall","year":"2012","unstructured":"Randall PA, Pardo M, Nunes EJ, L\u00f3pez Cruz L, Vemuri VK, Makriyannis A et al (2012) Dopaminergic modulation of effort-related choice behavior as assessed by a progressive ratio chow feeding choice task: pharmacological studies and the role of individual differences. Plos One 7(10):e47934. https:\/\/doi.org\/10.1371\/journal.pone.0047934","journal-title":"Plos One"},{"issue":"6","key":"6439_CR43","doi-asserted-by":"publisher","first-page":"e99320","DOI":"10.1371\/journal.pone.0099320","volume":"9","author":"PA Randall","year":"2014","unstructured":"Randall PA, Lee CA, Nunes EJ, Yohn SE, Nowak V, Khan B, Shah P, Pandit S, Vemuri VK, Makriyannis A, Baqi Y, M\u00fcller CE, Correa M, Salamone JD (2014) The VMAT-2 inhibitor tetrabenazine affects effort-related decision making in a progressive ratio\/chow feeding choice task: reversal with antidepressant drugs. Plos One 9(6):e99320","journal-title":"Plos One"},{"key":"6439_CR44","doi-asserted-by":"publisher","unstructured":"Reddy LF, Horan WP, Barch DM, Buchanan RW, Dunayevich E, Gold JM, Lyons N, Marder SR, Treadway MT, Wynn JK, Young JW, Green MF (2015) Effort-based decision-making paradigms for clinical trials in schizophrenia: Part 1\u2014Psychometric characteristics of 5 paradigms. Schizophr Bull 41(5):1045\u20131054. https:\/\/doi.org\/10.1093\/schbul\/sbv089","DOI":"10.1093\/schbul\/sbv089"},{"issue":"5","key":"6439_CR45","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1093\/schbul\/sbq083","volume":"36","author":"G Remington","year":"2010","unstructured":"Remington G, Kapur S (2010) Antipsychotic dosing: how much but also how often? Schiz Bull 36(5):900\u2013903. https:\/\/doi.org\/10.1093\/schbul\/sbq083","journal-title":"Schiz Bull"},{"key":"6439_CR46","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3389\/fphar.2019.00682","volume":"10","author":"RA Rotolo","year":"2019","unstructured":"Rotolo RA, Dragacevic V, Kalaba P, Urban K, Zehl M, Roller A, Wackerlig J, Langer T, Pistis M, De Luca MA, Caria F, Schwartz R, Presby RE, Yang JH, Samels S, Correa M, Lubec G, Salamone JD (2019) The novel atypical dopamine uptake inhibitor (S)-CE-123 partially reverses the effort-related effects of the dopamine depleting agent tetrabenazine and increases progressive ratio responding. Front Pharm 10:682. https:\/\/doi.org\/10.3389\/fphar.2019.00682","journal-title":"Front Pharm"},{"issue":"11","key":"6439_CR47","doi-asserted-by":"publisher","first-page":"3459","DOI":"10.1007\/s00213-020-05625-6","volume":"237","author":"RA Rotolo","year":"2020","unstructured":"Rotolo RA, Kalaba P, Dragacevic V, Presby RE, Neri J, Robertson E, Yang JH, Correa M, Bakulev V, Volkova NN, Pifl C, Lubec G, Salamone JD (2020) Behavioral and dopamine transporter binding properties of the modafinil analog (S, S)-CE-158: reversal of the motivational effects of tetrabenazine and enhancement of progressive ratio responding. Psychopharmacology 237(11):3459\u20133470. https:\/\/doi.org\/10.1007\/s00213-020-05625-6","journal-title":"Psychopharmacology"},{"key":"6439_CR48","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuropharm.2020.108325","author":"RA Rotolo","year":"2021","unstructured":"Rotolo RA, Presby RE, Tracey O, Asar S, Yang J-H, Correa M, Murray F, Salamone JD (2021) The Novel Atypical Dopamine Transport Inhibitor CT-005404 Reverses the Effort-Related Motivational Effects of Tetrabenazine and Interleukin-1\u03b2 and Increases Progressive Ratio Responding. Neuropharmacology. https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108325","journal-title":"Neuropharmacology"},{"key":"6439_CR49","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/S0166-4328(02)00282-6","volume":"137","author":"JD Salamone","year":"2002","unstructured":"Salamone JD, Correa M (2002) Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine. Behav Brain Res 137:3\u201325","journal-title":"Behav Brain Res"},{"key":"6439_CR50","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.neuron.2012.10.021","volume":"76","author":"JD Salamone","year":"2012","unstructured":"Salamone JD, Correa M (2012) The mysterious motivational functions of mesolimbic dopamine. Neuron 76:470\u2013485","journal-title":"Neuron"},{"key":"6439_CR51","doi-asserted-by":"publisher","DOI":"10.1042\/ETLS20220008","author":"JD Salamone","year":"2022","unstructured":"Salamone JD, Correa M (2022) Critical review of RDoC approaches to the study of motivation with animal models: effort valuation\/willingness to work. Emerg Top Life Sci. https:\/\/doi.org\/10.1042\/ETLS20220008","journal-title":"Emerg Top Life Sci"},{"issue":"4","key":"6439_CR52","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/BF02245659","volume":"104","author":"JD Salamone","year":"1991","unstructured":"Salamone JD, Steinpreis RE, McCullough LD, Smith P, Grebel D, Mahan K (1991) Haloperidol and nucleus accumbens dopamine depletion suppress lever pressing for food but increase free food consumption in a novel food choice procedure. Psychopharmacology 104(4):515\u2013521. https:\/\/doi.org\/10.1007\/BF02245659","journal-title":"Psychopharmacology"},{"key":"6439_CR53","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/0166-4328(94)90108-2","volume":"65","author":"JD Salamone","year":"1994","unstructured":"Salamone JD, Cousins MS, Bucher S (1994) Anhedonia or anergia? Effects of haloperidol and nucleus accumbens dopamine depletion on instrumental response selection in a T-maze cost\/benefit procedure. Behav Brain Res 65:221\u2013229","journal-title":"Behav Brain Res"},{"key":"6439_CR54","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/S0149-7634(96)00017-6","volume":"21","author":"JD Salamone","year":"1997","unstructured":"Salamone JD, Cousins MS, Snyder BJ (1997) Behavioral functions of nucleus accumbens DA: empirical and conceptual problems with the anhedonia hypothesis. Neurosci Biobehav Rev 21:341\u2013359","journal-title":"Neurosci Biobehav Rev"},{"key":"6439_CR55","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2174\/157340006776875914","volume":"2","author":"JD Salamone","year":"2006","unstructured":"Salamone JD, Correa M, Mingote SM, Weber SM, Farrar AM (2006) Nucleus accumbens dopamine and the forebrain circuitry involved in behavioral activation and effort-related decision making: implications for understanding anergia and psychomotor slowing in depression. Curr Psychiatry Rev 2:267\u2013280","journal-title":"Curr Psychiatry Rev"},{"key":"6439_CR56","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/s00213-006-0668-9","volume":"191","author":"JD Salamone","year":"2007","unstructured":"Salamone JD, Correa M, Farrar A, Mingote SM (2007) Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits. Psychopharmacology 191:461\u2013482","journal-title":"Psychopharmacology"},{"key":"6439_CR57","doi-asserted-by":"publisher","first-page":"377","DOI":"10.2217\/fnl.10.19","volume":"5","author":"JD Salamone","year":"2010","unstructured":"Salamone JD, Correa M, Farrar AM, Nunes EJ, Collins LE (2010) Role of dopamine-adenosine interactions in the brain circuitry regulating effort-related decision making: insights into pathological aspects of motivation. Future Neurol 5:377\u2013392","journal-title":"Future Neurol"},{"key":"6439_CR58","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1093\/brain\/aww050","volume":"139","author":"JD Salamone","year":"2016","unstructured":"Salamone JD, Yohn SE, Lopez-Cruz L, San Miguel N, Correa M (2016) Activational aspects of motivation: neural mechanisms and implications for psychopathology. Brain 139:1325\u20131347","journal-title":"Brain"},{"issue":"4","key":"6439_CR59","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1124\/pr.117.015107","volume":"70","author":"JD Salamone","year":"2018","unstructured":"Salamone JD, Correa M, Ferrigno S, Yang JH, Rotolo RA, Presby RE (2018) The Psychopharmacology of Effort-Related Decision Making: Dopamine, Adenosine, and Insights into the Neurochemistry of Motivation. Pharmacol Rev 70(4):747\u2013762","journal-title":"Pharmacol Rev"},{"key":"6439_CR60","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.brainresbull.2022.01.019","volume":"182","author":"JD Salamone","year":"2022","unstructured":"Salamone JD, Ecevitoglu A, Carratala-Ros C, Presby RE, Edelstein GA, Fleeher R, Rotolo RA, Meka N, Srinath S, Masthay JC, Correa M (2022) Complexities and paradoxes in understanding the role of dopamine in incentive motivation and instrumental action: Exertion of effort vs. anhedonia. Brain Res Bull 182:57\u201366. https:\/\/doi.org\/10.1016\/j.brainresbull.2022.01.019","journal-title":"Brain Res Bull"},{"issue":"4","key":"6439_CR61","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.pbb.2012.06.009","volume":"102","author":"JL Santerre","year":"2012","unstructured":"Santerre JL, Nunes EJ, Kovner R et al (2012) The novel adenosine A(2A) antagonist prodrug MSX-4 is effective in animal models related to motivational and motor functions. Pharmacol Biochem Behav 102(4):477\u2013487. https:\/\/doi.org\/10.1016\/j.pbb.2012.06.009","journal-title":"Pharmacol Biochem Behav"},{"issue":"6","key":"6439_CR62","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1037\/0735-7044.119.6.1687","volume":"119","author":"J Schweimer","year":"2005","unstructured":"Schweimer J, Saft S, Hauber W (2005) Involvement of catecholamine neurotransmission in the rat anterior cingulate in effort-related decision making. Behav Neurosci 119(6):1687\u20131692. https:\/\/doi.org\/10.1037\/0735-7044.119.6.1687","journal-title":"Behav Neurosci"},{"issue":"4","key":"6439_CR63","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1038\/npp.2016.173","volume":"42","author":"LE Sebel","year":"2017","unstructured":"Sebel LE, Graves SM, Chan CS, Surmeier DJ (2017) Haloperidol Selectively Remodels Striatal Indirect Pathway Circuits. Neuropsychopharmacology 42(4):963\u2013973. https:\/\/doi.org\/10.1038\/npp.2016.173","journal-title":"Neuropsychopharmacology"},{"issue":"4","key":"6439_CR64","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s00213-007-0988-4","volume":"196","author":"KS Sink","year":"2008","unstructured":"Sink KS, Vemuri VK, Olszewska T, Makriyannis A, Salamone JD (2008) Cannabinoid CB1 antagonists and dopamine antagonists produce different effects on a task involving response allocation and effort-related choice in food-seeking behavior. Psychopharmacology 196(4):565\u2013574. https:\/\/doi.org\/10.1007\/s00213-007-0988-4","journal-title":"Psychopharmacology"},{"key":"6439_CR65","doi-asserted-by":"publisher","first-page":"7","DOI":"10.4088\/JCP.v63n0102","volume":"63","author":"SM Stahl","year":"2002","unstructured":"Stahl SM (2002) The psychopharmacology of energy and fatigue. J Clin Psychiat 63:7\u20138","journal-title":"J Clin Psychiat"},{"issue":"Suppl 2","key":"6439_CR66","doi-asserted-by":"publisher","first-page":"S107","DOI":"10.1093\/schbul\/sbt197","volume":"40","author":"GP Strauss","year":"2014","unstructured":"Strauss GP, Waltz JA, Gold JM (2014) A review of reward processing and motivational impairment in schizophrenia. Schizophr Bull 40(Suppl 2):S107-166. https:\/\/doi.org\/10.1093\/schbul\/sbt197","journal-title":"Schizophr Bull"},{"issue":"1","key":"6439_CR67","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/s41537-021-00145-4","volume":"7","author":"GP Strauss","year":"2021","unstructured":"Strauss GP, Bartolomeo LA, Harvey PD (2021) Avolition as the core negative symptom in schizophrenia: relevance to pharmacological treatment development. NPJ Schizophr 7(1):16. https:\/\/doi.org\/10.1038\/s41537-021-00145-4","journal-title":"NPJ Schizophr"},{"key":"6439_CR68","doi-asserted-by":"publisher","first-page":"44","DOI":"10.3389\/fphar.2011.00044","volume":"2","author":"T Tan","year":"2011","unstructured":"Tan T, Watts SW, Davis RP (2011) Drug Delivery: Enabling Technology for Drug Discovery and Development. Iprecio Micro Infusion Pump: Programmable, Refillable, and Implantable. Front Pharmacol 2:44. https:\/\/doi.org\/10.3389\/fphar.2011.00044","journal-title":"Front Pharmacol"},{"key":"6439_CR69","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/7854_2022_355","volume":"58","author":"MT Treadway","year":"2022","unstructured":"Treadway MT, Salamone JD (2022) Vigor, Effort-Related Aspects of Motivation and Anhedonia. Curr Top Behav Neurosci 58:325\u2013353. https:\/\/doi.org\/10.1007\/7854_2022_355","journal-title":"Curr Top Behav Neurosci"},{"key":"6439_CR70","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.neubiorev.2010.06.006","volume":"35","author":"MT Treadway","year":"2011","unstructured":"Treadway MT, Zald DH (2011) Reconsidering anhedonia in depression: lessons from translational neuroscience. Neurosci Biobehav Rev 35:537\u2013555","journal-title":"Neurosci Biobehav Rev"},{"issue":"3","key":"6439_CR71","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1037\/a0028813","volume":"121","author":"MT Treadway","year":"2012","unstructured":"Treadway MT, Bossaller NA, Shelton RC, Zald DH (2012) Effort-based decision-making in major depressive disorder: a translational model of motivational anhedonia. J Abnorm Psychol 121(3):553\u2013558","journal-title":"J Abnorm Psychol"},{"issue":"2\u20133","key":"6439_CR72","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/j.schres.2014.11.024","volume":"161","author":"MT Treadway","year":"2015","unstructured":"Treadway MT, Peterman JS, Zald DH, Park S (2015) Impaired effort allocation in patients with schizophrenia. Schizophr Res 161(2\u20133):382\u2013385. https:\/\/doi.org\/10.1016\/j.schres.2014.11.024","journal-title":"Schizophr Res"},{"issue":"1","key":"6439_CR73","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s002130050593","volume":"137","author":"J Trevitt","year":"1998","unstructured":"Trevitt J, Atherton A, Aberman J, Salamone JD (1998) Effects of subchronic administration of clozapine, thioridazine and haloperidol on tests related to extrapyramidal motor function in the rat. Psychopharmacology 137(1):61\u201366. https:\/\/doi.org\/10.1007\/s002130050593","journal-title":"Psychopharmacology"},{"key":"6439_CR74","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00213-008-1396-0","volume":"203","author":"LT Worden","year":"2009","unstructured":"Worden LT, Shahriari M, Farrar AM, Sink KS, Hockemeyer J, M\u00fcller CE, Salamone JD (2009) The adenosine A2A antagonist MSX-3 reverses the effort-related effects of dopamine blockade: differential interaction with D1 and D2 family antagonists. Psychopharmacology 203:489\u2013499","journal-title":"Psychopharmacology"},{"key":"6439_CR75","first-page":"1161","volume":"11","author":"J Xiao","year":"2015","unstructured":"Xiao J, Mi W, Li L, Shi Y, Zhang H (2015) High relapse rate and poor medication adherence in the Chinese population with schizophrenia: results from an observational survey in the People\u2019s Republic of China. Neuropsychiatr Dis Treat 11:1161\u20137","journal-title":"Neuropsychiatr Dis Treat"},{"key":"6439_CR76","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00213-019-05343-8","volume":"237","author":"JH Yang","year":"2020","unstructured":"Yang JH, Presby RE, Jarvie AA, Rotolo RA, Fitch RH, Correa M, Salamone JD (2020) Pharmacological studies of effort-related decision making using mouse touchscreen procedures: effects of dopamine antagonism do not resemble reinforcer devaluation by removal of food restriction. Psychopharmacology 237:33\u201343. https:\/\/doi.org\/10.1007\/s00213-019-05343-8","journal-title":"Psychopharmacology"},{"issue":"7","key":"6439_CR77","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1007\/s00213-014-3766-0","volume":"232","author":"SE Yohn","year":"2015","unstructured":"Yohn SE, Thompson C, Randall PA, Lee CA, M\u00fcller CE, Baqi Y, Correa M, Salamone JD (2015) The VMAT-2 inhibitor tetrabenazine alters effort-related decision making as measured by the T-maze barrier choice task: reversal with the adenosine A2A antagonist MSX-3 and the catecholamine uptake blocker bupropion. Psychopharmacology 232(7):1313\u20131323. https:\/\/doi.org\/10.1007\/s00213-014-3766-0","journal-title":"Psychopharmacology"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-023-06439-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00213-023-06439-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-023-06439-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,18]],"date-time":"2023-09-18T06:06:39Z","timestamp":1695017199000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00213-023-06439-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,24]]},"references-count":77,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["6439"],"URL":"https:\/\/doi.org\/10.1007\/s00213-023-06439-y","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"type":"print","value":"0033-3158"},{"type":"electronic","value":"1432-2072"}],"subject":[],"published":{"date-parts":[[2023,8,24]]},"assertion":[{"value":"6 April 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research was supported by a grant from Lundbeck. JS has received grants from, and done consulting work for Shire, Prexa, Chronos, Blackthorn, Acadia, Otsuka, and Lundbeck. On behalf of all authors, the corresponding author states that there is no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interests"}}]}}